Literature DB >> 32502285

Prescription patterns of opioids and non-steroidal anti-inflammatory drugs in the first year after living kidney donation: An analysis of U.S. Registry and Pharmacy fill records.

Luke S Vest1, Nagaraju Sarabu2, Farrukh M Koraishy3, Minh-Tri Nguyen1, Meyeon Park4, Ngan N Lam5, Mark A Schnitzler1, David Axelrod6, Chi Yuan Hsu4, Amit X Garg7, Dorry L Segev8, Allan B Massie8, Gregory P Hess9, Bertram L Kasiske10, Krista L Lentine1.   

Abstract

We examined a novel database linking national donor registry identifiers to records from a US pharmaceutical claims warehouse (2007-2015) to describe opioid and NSAID prescription patterns among LKDs during the first year postdonation, divided into three periods: 0-14 days, 15-182 days, and 183-365 days. Associations of opioid and NSAID prescription fills with baseline factors were examined by logistic regression (adjusted odds ratio, LCL aORUCL ). Among 23,565 donors, opioid prescriptions were highest during days 0-14 (36.6%), but 12.6% of donors filled opioids during days 183-365. NSAID prescriptions rose from 0.5% during days 0-14 to 3.3% during days 183-365. Women filled opioids more commonly than men, and black donors filled both opioids and NSAIDs more commonly than white donors. After covariate adjustment, significant correlates of opioid prescription fills during days 183-365 included obesity (aOR,1.24 1.381.53 ), less than college education (aOR,1.19 1.311.43 ), smoking (aOR,1.33 1.451.58 ), and nephrectomy complications (aOR,1.11 1.291.49 ). NSAID prescription fills in year 1 were not associated with differences in estimated glomerular filtration rate, incidence of proteinuria or new-onset hypertension at the first and second year postdonation. Prescription fills for opioids and NSAIDs for LKDs varied with demographic and clinic traits. Future work should examine longer-term outcome implications to help inform safe analgesic regimen choices after donation.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  donors and donation; epidemiology; living kidney donor; pain management; pharmacy records; registries

Mesh:

Substances:

Year:  2020        PMID: 32502285      PMCID: PMC7449599          DOI: 10.1111/ctr.14000

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  47 in total

1.  NSAID use and progression of chronic kidney disease.

Authors:  Katherine Gooch; Bruce F Culleton; Braden J Manns; Jianguo Zhang; Helman Alfonso; Marcello Tonelli; Cy Frank; Scott Klarenbach; Brenda R Hemmelgarn
Journal:  Am J Med       Date:  2007-03       Impact factor: 4.965

2.  Ketorolac-based analgesia improves outcomes for living kidney donors.

Authors:  Stephen J Freedland; Malou Blanco-Yarosh; Jennifer C Sun; Susan J Hale; David A Elashoff; Mark S Litwin; Robert B Smith; Jacob Rajfer; H Albin Gritsch
Journal:  Transplantation       Date:  2002-03-15       Impact factor: 4.939

3.  Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation.

Authors:  K L Lentine; N N Lam; M A Schnitzler; G P Hess; B L Kasiske; H Xiao; D Axelrod; A X Garg; J D Schold; H Randall; N Dzebisashvili; D C Brennan; D L Segev
Journal:  Am J Transplant       Date:  2016-10-13       Impact factor: 8.086

4.  Analgesic use and renal function in men.

Authors:  K M Rexrode; J E Buring; R J Glynn; M J Stampfer; L D Youngman; J M Gaziano
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

5.  Perioperative Ketorolac Use: A Potential Risk Factor for Renal Dysfunction After Live-Donor Nephrectomy.

Authors:  Kazuhiro Takahashi; Anita K Patel; Shunji Nagai; Mohamed Safwan; Krishna G Putchakayala; William J Kane; Lauren E Malinzak; Jason E Denny; Atsushi Yoshida; Dean Y Kim
Journal:  Ann Transplant       Date:  2017-09-19       Impact factor: 1.530

6.  Prescription opioid use before and after heart transplant: Associations with posttransplant outcomes.

Authors:  Krista L Lentine; Kevin S Shah; Jon A Kobashigawa; Huiling Xiao; Zidong Zhang; David A Axelrod; Ngan N Lam; Dorry L Segev; Mara Ann McAdams-DeMarco; Henry Randall; Gregory P Hess; Hui Yuan; Luke S Vest; Bertram L Kasiske; Mark A Schnitzler
Journal:  Am J Transplant       Date:  2019-09-12       Impact factor: 8.086

7.  Association of bowel rest and ketorolac analgesia with short hospital stay after laparoscopic donor nephrectomy.

Authors:  Alberto Breda; Matthew H Bui; Joseph C Liao; Peter G Schulam
Journal:  Urology       Date:  2007-05       Impact factor: 2.649

8.  Gender differences in use of prescription narcotic medications among living kidney donors.

Authors:  Krista L Lentine; Ngan N Lam; Mark A Schnitzler; Amit X Garg; Huiling Xiao; Sheila E Leander; Daniel C Brennan; Sandra J Taler; David Axelrod; Dorry L Segev
Journal:  Clin Transplant       Date:  2015-09-18       Impact factor: 2.863

9.  Frequency and Associations of Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients With a Musculoskeletal Disorder and Hypertension, Heart Failure, or Chronic Kidney Disease.

Authors:  Zachary Bouck; Graham C Mecredy; Noah M Ivers; Moumita Barua; Danielle Martin; Peter C Austin; Joshua Tepper; R Sacha Bhatia
Journal:  JAMA Intern Med       Date:  2018-11-01       Impact factor: 21.873

10.  Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.

Authors:  Lawrence Scholl; Puja Seth; Mbabazi Kariisa; Nana Wilson; Grant Baldwin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-04       Impact factor: 17.586

View more
  2 in total

Review 1.  A practical guide for perioperative smoking cessation.

Authors:  Hiroki Iida; Tetsuya Kai; Michioki Kuri; Kumiko Tanabe; Masashi Nakagawa; Chizuru Yamashita; Hiroshi Yonekura; Mami Iida; Ikuo Fukuda
Journal:  J Anesth       Date:  2022-08-01       Impact factor: 2.931

Review 2.  Consensus statement on smoking cessation in patients with pain.

Authors:  Hiroki Iida; Shigeki Yamaguchi; Toru Goyagi; Yoko Sugiyama; Chie Taniguchi; Takako Matsubara; Naoto Yamada; Hiroshi Yonekura; Mami Iida
Journal:  J Anesth       Date:  2022-09-07       Impact factor: 2.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.